On June 11, 2024, Camlin Fine Sciences Limited announced that its wholly owned subsidiary, Dresen Quimica SAPI De CV, in Mexico, signed a Share Purchase Agreement (SPA). This agreement will acquire a 100% stake in Vitafor Invest NV, Belgium, along with its subsidiaries and associates. Details of the Acquired Entity The target entity is Vitafor …